MTS Medical AG, based in Konstanz, Germany, is a leading manufacturer of electrohydraulic extracorporeal shockwave systems (ESWT). The company was founded in 1996 by Nikolaus Hopfenzitz and Ralph Reitmajer to further develop and improve shockwave technology. MTS Medical is known for its patented Spark Wave Technology, which offers high treatment quality and effective results in various medical fields such as orthopedics, traumatology, wound care and urology.
The mission of MTS Medical is to advance regenerative medicine through innovative shockwave technologies and improve the quality of life of patients. The company attaches great importance to the satisfaction of patients and clinicians, which is achieved through continuous development of Spark Wave Technology.
MTS Medical is committed to sustainable medical solutions that focus on long-term effectiveness and patient satisfaction. Through collaboration with international research institutions and continuous improvement of technology, the company contributes to the development of environmentally friendly and efficient medical treatment methods.
Through the close partnership with companies such as SoftWave Tissue Regeneration Technologies LLC, research and development in the field of shockwave therapy is further strengthened, leading to significant advances in the treatment of wounds and tissue regeneration.
